A risk prediction model for contrast-induced nephropathy associated with gadolinium-based contrast agents.

Zheng, Huanhuan; Wang, Guolang; Cao, Qianqian; Ren, Wenkai; Xu, Lingyuan; Bu, Shuangshan

Zheng, Huanhuan; Wang, Guolang; Cao, Qianqian; Ren, Wenkai; Xu, Lingyuan; Bu, Shuangshan.

Afiliação

Zheng H; Department of Nephrology, Affiliated Dongyang Hospital of Wenzhou Medical University, Zhejiang, China.
Wang G; Department of Vascular Surgery, Affiliated Dongyang Hospital of Wenzhou Medical University, Zhejiang, China.
Cao Q; Department of Nephrology, Affiliated Dongyang Hospital of Wenzhou Medical University, Zhejiang, China.
Ren W; Department of Nephrology, Affiliated Dongyang Hospital of Wenzhou Medical University, Zhejiang, China.
Xu L; Department of Nephrology, Affiliated Dongyang Hospital of Wenzhou Medical University, Zhejiang, China.
Bu S; Department of Nephrology, Affiliated Dongyang Hospital of Wenzhou Medical University, Zhejiang, China.

Ren Fail ; 44(1): 741-747, 2022 Dec.

Article em En | MEDLINE | ID: mdl-35509178

Assuntos

Meios de Contraste; Nefropatias; Albuminas; Glicemia; Meios de Contraste/efeitos adversos; Feminino; Furosemida; Gadolínio/efeitos adversos; Humanos; Nefropatias/induzido quimicamente; Masculino; Curva ROC; Estudos Retrospectivos; Fatores de Risco

Palavras-chave

Contrast-induced nephropathy; gadolinium-based contrast agent; nephrotoxicity; prediction model

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Meios de Contraste / Nefropatias Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google